Open in interactive viewer → charts, metric popovers & call review

Pinnacle: Growth Machine Grinds On, But Margin and Merger Overhead Keep a Lid on the Multiple

Combined firm delivers double-digit loan growth and record hiring, yet NIM falls and P/B sits below 1x — a classic execution-beats-letter story.
PNFP · Earnings Call · 2026-07-23

The growth engine is firing

The second-quarter report from Pinnacle Financial Partners is a study in committed execution. CEO Kevin Blair opened the call with the now-familiar mantra: “We have remained focused on the leverage points that help us deliver on our commitments and continue a long and proud heritage of growth and success.” — Kevin Blair, President and CEO · 2026-07-23 And the numbers bear it out. Adjusted diluted EPS rose 25% year-over-year, or, as CFO Jamie Gregory noted, “Adjusted diluted EPS increased 5% versus the prior quarter and 25% of our second quarter 2025 results.” — Andrew Gregory, Chief Financial Officer · 2026-07-23 The engine is clearly the post-merger growth: loans expanded $2.9 billion (14% annualized), core deposits grew $963 million excluding public fund seasonality, and 74 experienced revenue producers were added in the quarter, with another 34 already signed for July. The growth in NII remains the core shareholder driver; Jamie projected steady 2% sequential NII increases through the year, underpinned by prior-year hiring that carries little marginal expense. "We're not competing on price," Kevin insisted, pointing to new production spreads that actually widened in 6 of 8 geographies. The company is hitting the top end of its loan guidance and maintaining deposit-growth momentum—a new production mix that investors have learned to trust from this franchise.

Margin grind and the liquidity build

What is new—and what the market is still weighing—is the visible compression in net interest margin. NIM fell 9 basis points to 3.44%, a decline Jamie attributed to three factors: lower SOFR, slower prepayments on C&I loans, and the deliberate build of securities to assets as the bank transitions into a Category IV liquidity regime. "We are acclimating into being a Cat IV bank," Kevin explained, "so you see debt issuance, you see building cash and securities that at some point is going to be done." The company issued $750 million of senior debt and repositioned roughly $1 billion of municipal securities. Management is explicit that this is a temporary drag—they now guide full-year NIM to 3.44–3.47%, with a long-term floor near 3.30%. The market's worry is whether the growth model can outpace the margin grind. Jamie countered: "Even in that marginal growth where we're funding it with wholesale funding, it's accretive to the shareholder because we're able to maintain return on tangible common equity because expense growth is happening at a much slower rate." Indeed, the efficiency ratio came in at 49.8%, and deposit ratio stability suggests the funding side is under control.

Fee income, BHG, and the heartbeat of the model

Beyond the balance sheet, fee income is a growing pillar. Core banking, wealth management, and capital markets all posted double-digit year-over-year growth, with capital markets benefiting from expanded syndication and revenue synergies that are "on track" toward the $130 million target. The BHG partnership remains a unique torque point; after a distribution pause that trimmed Q2 investment income by $7 million, Jamie reported that flows have resumed and "we raised our revenue guide on the investment side for 2026." BHG production is up nearly $1 billion sequentially—a reminder that this minority investment continues to throw off cash even as the core bank integrates. On the hiring front, Kevin reiterated the power of the model: "When you hire revenue producer, they bring Rolodex with them. And they talk to our team about which team members need to join with them." That self-reinforcing flywheel is the same pitch we heard in prior calls, but the scale is now larger with the Synovus footprint becoming a hiring engine.

We are not declaring victory. We are 6 months in and there is more to execute.

Kevin Blair, President and CEO · 2026-07-23

A valuation disconnect worth watching

The real tension is between operational excellence and market perception. The stock trades at a Price to Book of just 0.9x, a level that historically signals deep skepticism about the sustainability of the growth or the terminal margin. Yet the company is compounding tangible equity at a 17.7% adjusted ROTCE, and CET1 is building toward its 10.25% target (9.93% at quarter-end, plus an expected 40 bps from the Fed NPR). The 90-day price tape shows a +10.5% rebound, but the stock is still 21% below its November 2024 peak. As Jamie put it: "We believe that this does derisk external perceptions of our outlook going forward." The market may be waiting for the systems conversion in March 2027 to prove the synergy math, but the evidence from the past two quarters—double-digit loan growth, stable credit, and an unbroken hiring run—suggests the growth engine is real. The question is whether investors will eventually reward it with a multiple that reflects the compounding rather than the fears. Prior calls sound the same note of conviction: Kevin said in Q1 2026, "John, it's a great question. As we've talked about the first quarter, I think, answered the question of whether the combined companies can continue to grow." And Jamie added, "As we look into 2026, we do expect to see deposit growth to be more back-end loaded." Those commitments are holding, and the proof point this quarter is the combination of growth, recruiting, and credit discipline. For a bank that has consistently compounded above its peer set, the low valuation is either a trailing artifact or a genuine opportunity. Betting on the former is the essence of the Pinnacle story. One final note: the public fund dynamics are a seasonal headwind/benefit that management has handled with discipline, and the outsize growth narrative remains intact. Investors who look past the NIM noise and the merger integration costs may find an underappreciated compounder.